Steven Swanson | Senior Vice President, Research
Immunocellular Therapeutics

Appearances:

Day One @ 16:20

Novel personalized immune therapies for solid tumors

•     Mobilizing the immune system through patient specific biomarkers
•     Designing Ph III immunotherapy trials incorporating lessons from Ph II
•     Manufacturing: why producing sufficient cells is a challenge and how to overcome this through optimized mixing, aeration, and perfusion